Evofem Biosciences Analysis

Evofem OTC Stock Analysis Notes

The company recorded a loss per share of 19.01. Evofem Biosciences last dividend was issued on the 18th of January 2018. The entity had 1:15 split on the 6th of May 2022. Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in womens sexual and reproductive health. Evofem Biosciences, Inc. is headquartered in San Diego, California. Evofem Biosciences operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 119 people.The quote for Evofem Biosciences is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To learn more about Evofem Biosciences call the company at 858 550 1900 or check out https://www.evofem.com.

Evofem Biosciences Investment Alerts

Evofem Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.41 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Evofem Biosciences's market, we take the total number of its shares issued and multiply it by Evofem Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Evofem Biosciences Outstanding Bonds

Evofem Biosciences Predictive Daily Indicators

OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Evofem Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Evofem shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Evofem Biosciences. By using and applying Evofem OTC Stock analysis, traders can create a robust methodology for identifying Evofem entry and exit points for their positions.

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in census. Note that the Evofem Biosciences information on this page should be used as a complementary analysis to other Evofem Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

If you are still planning to invest in Evofem Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Evofem Biosciences' history and understand the potential risks before investing.